Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Harvala, Heli ; Reynolds, Claire ; Brailsford, Su ; Davison, Katy
• Description:
  In England, all blood donations are screened in pools of 24 by nucleic acid test (NAT) for hepatitis E virus (HEV) RNA. During 2016-2020, this screening successfully identified and intercepted 1,727 RNA-positive donations. However, review of previous donations from infected platelet donors identified 9 donations in which HEV RNA detection was missed, of which 2 resulted in confirmed transmission: 1 infection resolved with ribavirin treatment, and 1 proceeded to fatal multiorgan failure within a month from infection. Residual risk calculations predict that over the 5-year study period, HEV RNA detection was missed by minipool NAT in 12-23 platelet and 177-354 whole-blood donations, but transmission risk remains undetermined. Although screening has been able to largely eliminate infectious HEV from the blood supply in England, missed detection of low levels of HEV RNA in donated blood can lead to a severe, even fulminant, infection in recipients and could be prevented by more sensitive screening.
• Subjects:
  Blood Donors Blood Transfusion Hepatitis E Hepatitis E Virus Humans Mass Screening Rna, Viral
• Source:
  Emerg Infect Dis. 2022; 28(9):1805-1813
• Pubmed ID:
  35997399
• Pubmed Central ID:
  PMC9423923
• Document Type:
  Journal Article
• Place as Subject:
  England
• Volume:
  28
• Issue:
  9
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:4bd114f1ec074c8060d85be03b2e778ae24c58011fefbad38bb2c46c91bcf578
• Download URL:
  https://stacks.cdc.gov/view/cdc/121051/cdc_121051_DS1.pdf
• File Type:
  [PDF - 2.01 MB ]